Philip Jull
Président chez ARROW EXPLORATION CORP.
Fortune : 2 M $ au 31/05/2024
Profil
Philip Gage Jull was the founder of Bordeaux Capital, Inc. (founded in 2015) where he held the title of Chairman from 2015 to 2022.
He currently holds the position of Executive Chairman at Arrow Exploration Corp.
since 2020, Chairman at Tryp Therapeutics, Inc., Director at GeneTether, Inc., Independent Director at GeneTether Therapeutics, Inc. since 2021, and Non-Executive Director at Tryptamine Therapeutics Ltd.
starting in 2024.
Mr. Jull previously served as an Independent Director at Aldridge Minerals, Inc. and as Managing Director-Corporate Finance at Research Capital Corp.
from 2004 to 2015.
He obtained an undergraduate degree from the University of Toronto and an MBA from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARROW EXPLORATION CORP.
2,10% | 29/04/2024 | 5 993 508 ( 2,10% ) | 2 M $ | 31/05/2024 |
| 07/03/2023 | 148 919 ( 0,39% ) | 3 723 $ | 31/05/2024 |
Postes actifs de Philip Jull
| Sociétés | Poste | Début |
|---|---|---|
| ARROW EXPLORATION CORP. | Président | 21/03/2020 |
| TRYPTAMINE THERAPEUTICS LIMITED | Président | - |
| GENETETHER THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/10/2021 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Directeur/Membre du Conseil | - |
Anciens postes connus de Philip Jull
| Sociétés | Poste | Fin |
|---|---|---|
Bordeaux Capital, Inc.
 Bordeaux Capital, Inc. Investment ManagersFinance Bordeaux Capital, Inc. focuses on generating and executing transformative financial advisory solutions for public and private corporations. The company was founded by Jaret Anderson, Gage Jull and Max Satel and is headquartered in Toronto, Canada. | Fondateur | 01/01/2022 |
Research Capital Corp.
 Research Capital Corp. Investment ManagersFinance Research Capital Corp. is an independent, fully integrated national investment dealer headquartered in Toronto, Canada. The firm was founded in 2010 as Mackie Research Capital Corp. until 2021. Research Capital offers a complete range of capital markets and wealth management services to private clients, institutions and growth companies with offices across Canada. | Corporate Officer/Principal | 01/11/2015 |
| ALDRIDGE MINERALS INC. | Directeur/Membre du Conseil | - |
Formation de Philip Jull
| University of Toronto | Undergraduate Degree |
| University of Western Ontario | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARROW EXPLORATION CORP. | Energy Minerals |
| GENETETHER THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Bordeaux Capital, Inc.
Bordeaux Capital, Inc. Investment ManagersFinance Bordeaux Capital, Inc. focuses on generating and executing transformative financial advisory solutions for public and private corporations. The company was founded by Jaret Anderson, Gage Jull and Max Satel and is headquartered in Toronto, Canada. | Finance |
Aldridge Minerals, Inc.
 Aldridge Minerals, Inc. Precious MetalsNon-Energy Minerals Aldridge Minerals, Inc. is a development stage mining company. It engages in the business of identifying, acquiring, exploring, and developing mineral properties. The company was founded on June 6, 1994 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Research Capital Corp.
Research Capital Corp. Investment ManagersFinance Research Capital Corp. is an independent, fully integrated national investment dealer headquartered in Toronto, Canada. The firm was founded in 2010 as Mackie Research Capital Corp. until 2021. Research Capital offers a complete range of capital markets and wealth management services to private clients, institutions and growth companies with offices across Canada. | Finance |
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
